Atomistry » Chlorine » PDB 5aaa-5afy » 5aep
Atomistry »
  Chlorine »
    PDB 5aaa-5afy »
      5aep »

Chlorine in PDB 5aep: Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders

Enzymatic activity of Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders

All present enzymatic activity of Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders:
2.7.10.2;

Protein crystallography data

The structure of Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders, PDB code: 5aep was solved by G.Canevari, J.Bertrand, M.G.Brasca, M.Nesi, N.Amboldi, N.Avanzi, S.Bindi, D.Casero, M.Ciomei, N.Colombo, S.Cribioli, G.Fachin, E.R.Felder, A.Galvani, A.Isacchi, I.Motto, A.Panzeri, P.Gnocchi, D.Donati, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 68.79 / 1.95
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 93.740, 101.260, 67.550, 90.00, 90.00, 90.00
R / Rfree (%) 17.114 / 21.335

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders (pdb code 5aep). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders, PDB code: 5aep:

Chlorine binding site 1 out of 1 in 5aep

Go back to Chlorine Binding Sites List in 5aep
Chlorine binding site 1 out of 1 in the Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl2000

b:34.2
occ:1.00
 CL A:QUP2000 0.0 34.2 1.0
C19 A:QUP2000 1.8 26.6 1.0
C21 A:QUP2000 2.8 29.0 1.0
C18 A:QUP2000 2.8 26.5 1.0
O A:GLY861 3.3 34.6 1.0
CA A:SER862 3.5 30.9 1.0
N A:GLY858 3.6 46.4 1.0
C A:GLY861 3.6 36.2 1.0
CA A:LYS857 3.6 42.7 1.0
O A:GLY856 3.6 33.5 1.0
C A:LYS857 3.7 48.0 1.0
N A:LYS857 3.8 35.7 1.0
N A:SER862 3.8 32.2 1.0
C A:GLY856 3.9 38.3 1.0
C A:SER862 3.9 31.0 1.0
N A:VAL863 4.0 25.8 1.0
CG2 A:VAL863 4.0 25.5 1.0
C22 A:QUP2000 4.0 24.2 1.0
C17 A:QUP2000 4.1 22.4 1.0
O A:LYS857 4.4 49.5 1.0
CA A:GLY861 4.5 37.7 1.0
C23 A:QUP2000 4.5 22.5 1.0
CA A:GLY858 4.6 54.1 1.0
CE A:LYS882 4.6 24.7 1.0
CB A:VAL863 4.8 25.5 1.0
O A:SER862 4.8 26.7 1.0
O A:GLY858 4.8 60.3 1.0
CB A:SER862 4.8 39.5 1.0
O A:HOH2019 4.8 58.9 1.0
CA A:GLY856 4.9 33.1 1.0
CA A:VAL863 5.0 30.4 1.0

Reference:

M.G.Brasca, P.Gnocchi, M.Nesi, N.Amboldi, N.Avanzi, J.Bertrand, S.Bindi, G.Canevari, D.Casero, M.Ciomei, N.Colombo, S.Cribioli, G.Fachin, E.R.Felder, A.Galvani, A.Isacchi, I.Motto, A.Panzeri, D.Donati. Novel Pyrrole Carboxamide Inhibitors of JAK2 As Potential Treatment of Myeloproliferative Disorders. Bioorg.Med.Chem. V. 23 2387 2015.
ISSN: ISSN 0968-0896
PubMed: 25882525
DOI: 10.1016/J.BMC.2015.03.059
Page generated: Sat Jul 12 00:10:58 2025

Last articles

Fe in 8PP3
Fe in 8PTV
Fe in 8PP2
Fe in 8P8G
Fe in 8POZ
Fe in 8POX
Fe in 8POY
Fe in 8POW
Fe in 8POU
Fe in 8POV
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy